Therapeutic potential of esculetin in various cancer types (Review)
Oncology Letters · 08.05.2024 · 28 (1)
DOI: 10.3892/ol.2024.14438 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Letters, online erschienen am 08.05.2024. Verfasst von Mengying Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Esculetin (Esc), a coumarin derivative and herbal medicinal compound used in traditional Chinese medicine, is extracted from Fraxinus chinensis. Esc has shown notable potential in the inhibition of proliferation, metastasis and cell cycle arrest in various cancer cell lines. The present review is based on research articles regarding Esc in the field of carcinoma, published between 2009 and 2023. These studies have unanimously demonstrated that Esc can effectively inhibit cancer cell proliferation through diverse mechanisms and modulate multiple signaling pathways, such as Wnt/β-catenin, PI3K/Akt, MAPK and janus kinase/signal transducer and activator of transcription-3. In addition, the safety profile of Esc has been demonstrated in credible animal experiments, which has indicated Esc as an effective compound. Furthermore, the combination therapy of Esc with commonly used chemotherapeutic drugs holds great promise. The aim of the present review was to encourage further studies and applications of Esc in cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medicine, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
- Teaching Department, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
- Department of Clinical Medicine, Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Zitieren
APA
Liu, M., Sheng, Y., Guo, F., Wu, J., Huang, Y., Yang, X., Wang, M., Zhang, S., & Li, P. (2024). Therapeutic potential of esculetin in various cancer types (Review). Oncology Letters, 28(1). https://doi.org/10.3892/ol.2024.14438
Vancouver
Liu M, Sheng Y, Guo F, Wu J, Huang Y, Yang X, et al. Therapeutic potential of esculetin in various cancer types (Review). Oncology Letters. 2024;28(1). doi:10.3892/ol.2024.14438
BibTeX
@article{Liu2024,
author = {Liu, Mengying and Sheng, Yuyan and Guo, Fangyue and Wu, Jing and Huang, Yufei and Yang, Xiaoning and Wang, Mengying and Zhang, Shanfeng and Li, Pei},
title = {Therapeutic potential of esculetin in various cancer types (Review)},
journal = {Oncology Letters},
year = {2024},
volume = {28},
number = {1},
doi = {10.3892/ol.2024.14438}
}
EUVIMED